Will Parsons was appointed as chief of the Division of Hematology-Oncology in the Department of Pediatrics at Baylor College of Medicine and director of Texas Children’s Cancer and Hematology Center, effective immediately.
A phase III clinical trial will soon begin testing the evidence collected thus far that points to a stunning prospect: the COVID-19 vaccine—a widely accessible mRNA vaccine already on the market—could make checkpoint inhibitors work better for lung cancer and melanoma patients.
